BioNexus Gene Lab (BGLC) Non Operating Investment Income (2024 - 2025)
BioNexus Gene Lab (BGLC) reported Non Operating Investment Income of -$28256.0 for Q4 2025, up 83.72% on a YoY basis from -$15379.6 in Q4 2024, and down 219.01% sequentially from $23742.0 in Q2 2025.
BioNexus Gene Lab (BGLC) Non Operating Investment Income (2024 - 2025) Analysis & Trends
BioNexus Gene Lab (BGLC) has 2 years of Non Operating Investment Income data on file, last reported at -$28256.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Investment Income rose 83.72% year-over-year to -$28256.0; the trailing twelve-month figure through Mar 2026 stood at -$4514.0 (up 58.18% YoY), and the FY2024 full-year result was $69476.0, down 77.34% from the prior year.
- Non Operating Investment Income retreated to -$28256.0 in Q4 2025, from $23742.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $88532.0 in Q2 2024 to a low of -$173607.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | - |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | - |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | - |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | - |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | - |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | - |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | 275.90 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | - |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | - |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28,256.00 |
| Dec 31, 2025 | -28,256.00 |
| Jun 30, 2025 | 23,742.00 |
| Jun 30, 2025 | 23,742.00 |
| Mar 31, 2025 | 4,514.00 |
| Mar 31, 2025 | 4,514.00 |
| Dec 31, 2024 | -173,607.00 |
| Dec 31, 2024 | -173,607.00 |
| Sep 30, 2024 | 69,766.00 |
| Sep 30, 2024 | 69,766.00 |
| Jun 30, 2024 | 88,532.00 |
| Jun 30, 2024 | 88,532.00 |
| Mar 31, 2024 | 84,785.00 |
| Mar 31, 2024 | 84,785.00 |